BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27379929)

  • 1. KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL.
    Zhu L; Xiao F; Yu Y; Wang H; Fang M; Yang Y; Sun H; Wang L; Sheng Y
    Anticancer Drugs; 2016 Oct; 27(9):863-72. PubMed ID: 27379929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells.
    Yin Y; Sun H; Xu J; Xiao F; Wang H; Yang Y; Ren H; Wu CT; Gao C; Wang L
    Leuk Lymphoma; 2015 Jun; 56(6):1813-20. PubMed ID: 25146433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway.
    Song IS; Jeong YJ; Nyamaa B; Jeong SH; Kim HK; Kim N; Ko KS; Rhee BD; Han J
    BMB Rep; 2015 Oct; 48(10):571-6. PubMed ID: 25772758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.
    Carter BZ; Mak DH; Woessner R; Gross S; Schober WD; Estrov Z; Kantarjian H; Andreeff M
    Leukemia; 2009 Oct; 23(10):1755-62. PubMed ID: 19458629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Kinesin spindle protein inhibits proliferation, induces apoptosis and increases chemosensitivity in hepatocellular carcinoma cells.
    Doan CC; Doan NT; Nguyen QH; Nguyen MH; Do MS; Le VD
    Iran Biomed J; 2015; 19(1):1-16. PubMed ID: 25605484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
    Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
    Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway.
    Ferreira AK; Meneguelo R; Pereira A; Filho OM; Chierice GO; Maria DA
    Biomed Pharmacother; 2013 Jul; 67(6):481-7. PubMed ID: 23773853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma.
    Bongero D; Paoluzzi L; Marchi E; Zullo KM; Neisa R; Mao Y; Escandon R; Wood K; O'Connor OA
    Leuk Lymphoma; 2015; 56(10):2945-52. PubMed ID: 25860245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methylpyridine-1-ium-1-sulfonate from Allium hirtifolium: An anti-angiogenic compound which inhibits growth of MCF-7 and MDA-MB-231 cells through cell cycle arrest and apoptosis induction.
    Mohammadi-Motlagh HR; Shokohinia Y; Mojarrab M; Rasouli H; Mostafaie A
    Biomed Pharmacother; 2017 Sep; 93():117-129. PubMed ID: 28624423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520.
    Tunquist BJ; Woessner RD; Walker DH
    Mol Cancer Ther; 2010 Jul; 9(7):2046-56. PubMed ID: 20571074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
    Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD
    FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of inhibition of human KSP by ispinesib.
    Lad L; Luo L; Carson JD; Wood KW; Hartman JJ; Copeland RA; Sakowicz R
    Biochemistry; 2008 Mar; 47(11):3576-85. PubMed ID: 18290633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
    Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB
    Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.
    Park EY; Woo Y; Kim SJ; Kim DH; Lee EK; De U; Kim KS; Lee J; Jung JH; Ha KT; Choi WS; Kim IS; Lee BM; Yoon S; Moon HR; Kim HS
    Int J Biol Sci; 2016; 12(12):1555-1567. PubMed ID: 27994519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.